InsiderTrades

Form 4 for PETS PETMED EXPRESS INC

Accepted 2025-01-17 00:00:00 ET · period of report 2025-01-15 · accession 0001040130-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-01-17 2025-01-15 PETS Campos Sandra Yvette CEO, Pres, Dir A - Grant $0.00 +146.8K 639.0K +30% $0
D 2025-01-17 2025-01-15 PETS Campos Sandra Yvette CEO, Pres, Dir A - Grant $0.00 +146.8K 146.8K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-01-15 A A 146,772 $0.00 638,987 D — — (F1) Consists of restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of January 15, 2025, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.
2 Derivative Performance Share Units 2025-01-15 A A 146,772 $0.00 146,772 D — · — to 2027-12-31 146,772 Common Stock (F2) Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2027.